ENST00000574453.5:n.*4372C>T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The ENST00000574453.5(MINK1):​n.*4372C>T variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.818 in 145,204 control chromosomes in the GnomAD database, including 48,638 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.82 ( 48638 hom., cov: 23)
Exomes 𝑓: 0.76 ( 114 hom. )
Failed GnomAD Quality Control

Consequence

MINK1
ENST00000574453.5 non_coding_transcript_exon

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 0.238

Publications

5 publications found
Variant links:
Genes affected
MINK1 (HGNC:17565): (misshapen like kinase 1) This gene encodes a serine/threonine kinase belonging to the germinal center kinase (GCK) family. The protein is structurally similar to the kinases that are related to NIK and may belong to a distinct subfamily of NIK-related kinases within the GCK family. Studies of the mouse homolog indicate an up-regulation of expression in the course of postnatal mouse cerebral development and activation of the cJun N-terminal kinase (JNK) and the p38 pathways. [provided by RefSeq, Mar 2016]
CHRNE (HGNC:1966): (cholinergic receptor nicotinic epsilon subunit) Acetylcholine receptors at mature mammalian neuromuscular junctions are pentameric protein complexes composed of four subunits in the ratio of two alpha subunits to one beta, one epsilon, and one delta subunit. The acetylcholine receptor changes subunit composition shortly after birth when the epsilon subunit replaces the gamma subunit seen in embryonic receptors. Mutations in the epsilon subunit are associated with congenital myasthenic syndrome. [provided by RefSeq, Sep 2009]
CHRNE Gene-Disease associations (from GenCC):
  • congenital myasthenic syndrome
    Inheritance: AR Classification: DEFINITIVE Submitted by: Illumina
  • congenital myasthenic syndrome 4A
    Inheritance: AD, AR Classification: STRONG Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), PanelApp Australia
  • congenital myasthenic syndrome 4B
    Inheritance: AR Classification: STRONG Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), PanelApp Australia
  • congenital myasthenic syndrome 4C
    Inheritance: AR Classification: STRONG Submitted by: Genomics England PanelApp
  • postsynaptic congenital myasthenic syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BP6
Variant 17-4897991-C-T is Benign according to our data. Variant chr17-4897991-C-T is described in ClinVar as [Benign]. Clinvar id is 323958.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.858 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MINK1NM_153827.5 linkc.*704C>T 3_prime_UTR_variant Exon 32 of 32 ENST00000355280.11 NP_722549.2 Q8N4C8-1
CHRNENM_000080.4 linkc.*745G>A 3_prime_UTR_variant Exon 12 of 12 ENST00000649488.2 NP_000071.1 Q04844

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MINK1ENST00000355280.11 linkc.*704C>T 3_prime_UTR_variant Exon 32 of 32 1 NM_153827.5 ENSP00000347427.6 Q8N4C8-1
CHRNEENST00000649488.2 linkc.*745G>A 3_prime_UTR_variant Exon 12 of 12 NM_000080.4 ENSP00000497829.1 Q04844

Frequencies

GnomAD3 genomes
AF:
0.818
AC:
118638
AN:
145086
Hom.:
48601
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.728
Gnomad AMI
AF:
0.949
Gnomad AMR
AF:
0.864
Gnomad ASJ
AF:
0.869
Gnomad EAS
AF:
0.742
Gnomad SAS
AF:
0.794
Gnomad FIN
AF:
0.829
Gnomad MID
AF:
0.856
Gnomad NFE
AF:
0.864
Gnomad OTH
AF:
0.847
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.765
AC:
283
AN:
370
Hom.:
114
Cov.:
0
AF XY:
0.776
AC XY:
132
AN XY:
170
show subpopulations
African (AFR)
AC:
0
AN:
0
American (AMR)
AF:
0.850
AC:
34
AN:
40
Ashkenazi Jewish (ASJ)
AF:
1.00
AC:
4
AN:
4
East Asian (EAS)
AF:
0.500
AC:
1
AN:
2
South Asian (SAS)
AF:
0.792
AC:
19
AN:
24
European-Finnish (FIN)
AF:
0.864
AC:
19
AN:
22
Middle Eastern (MID)
AF:
1.00
AC:
2
AN:
2
European-Non Finnish (NFE)
AF:
0.752
AC:
191
AN:
254
Other (OTH)
AF:
0.591
AC:
13
AN:
22
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.522
Heterozygous variant carriers
0
3
5
8
10
13
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.818
AC:
118733
AN:
145204
Hom.:
48638
Cov.:
23
AF XY:
0.817
AC XY:
57681
AN XY:
70630
show subpopulations
African (AFR)
AF:
0.728
AC:
29279
AN:
40238
American (AMR)
AF:
0.864
AC:
12621
AN:
14604
Ashkenazi Jewish (ASJ)
AF:
0.869
AC:
2929
AN:
3372
East Asian (EAS)
AF:
0.742
AC:
3721
AN:
5018
South Asian (SAS)
AF:
0.794
AC:
3685
AN:
4642
European-Finnish (FIN)
AF:
0.829
AC:
7833
AN:
9446
Middle Eastern (MID)
AF:
0.853
AC:
232
AN:
272
European-Non Finnish (NFE)
AF:
0.864
AC:
55914
AN:
64742
Other (OTH)
AF:
0.847
AC:
1695
AN:
2002
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.513
Heterozygous variant carriers
0
744
1488
2231
2975
3719
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
836
1672
2508
3344
4180
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.724
Hom.:
2595

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Congenital myasthenic syndrome Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.86
CADD
Benign
1.7
DANN
Benign
0.52
PhyloP100
0.24
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
2.2
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1053751; hg19: chr17-4801286; API